All In MedTech

Device Trial Radar · NCT05886894

Air Optix Plus HydraGlyde Multifocal Daily/Extended Wear Contact Lenses

Last checked: Nov 20, 2026Latest source record: Aug 14, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

351

Actual

Start

Aug 8, 2023

Primary completion

Jun 20, 2025

Study completion Jun 20, 2025

Sponsor

Lead sponsor
Alcon ResearchNot on our public-company list
Sponsor type
Industry
First posted
Jun 2, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this Post-Market Clinical Follow-Up (PMCF) study is to assess long term performance and safety of Air Optix plus HydraGlyde Multifocal soft contact lenses in a real-world setting when worn as daily wear or extended (overnight) wear.

Conditions

  • Refractive Errors

Interventions

  • Lotrafilcon B multifocal soft contact lensesDevice

    Commercially available soft (hydrophilic) contact lenses indicated for the correction of presbyopia, with or without myopia or hyperopia

  • Comfilcon A multifocal soft contact lensesDevice

    Commercially available soft (hydrophilic) contact lenses indicated for the correction of refractive ametropia (myopia and hyperopia) and emmetropia with presbyopia

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Distance visual acuity at 1 year - Daily WearTime frame: Year 1
  2. Near visual acuity at 1 year - Daily WearTime frame: Year 1
  3. Distance visual acuity at 3 years - Extended WearTime frame: Year 3

5 more outcomes with a free account

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Complete Family Vision Care

    San Diego, California

  • Pearle Vision

    Jacksonville, Florida

  • Jackson Health Community Center

    Miami, Florida

5 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.